Nifedipine Tablet, Extended Release
Product Images NDC 51655-780

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 780 52 Master Bottle Label Approval Rev A 08 21)

Label for Nifedipine Extended-Release Tablets, USP, 60 mg, containing 30 tablets. The label includes storage instructions to keep at 20°-25°C and warnings to protect from light and moisture. It lists the manufacturer as Northwind Health Company, LLC, and shows the NDC number 51655-780-52.*

FDA Label Image

Image1 (Image 01)

Chemical structure diagram of nifedipine, showing a dihydropyridine ring with multiple substituents including methyl, methoxycarbonyl, acetyl, nitro groups, and a phenyl ring.*

FDA Label Image

Image2 (Image 02)

Data table showing mean reductions in trough supine blood pressure (systolic/diastolic in mmHg) for nifedipine extended-release tablets at doses of 30 mg, 60 mg, and 90 mg from two studies. It provides sample size (N) and mean trough reductions with placebo response subtracted for each dose in both studies.*

FDA Label Image

Image3 (Image 03)

A data table summarizing the percentage of subjects experiencing various adverse effects during treatment with Nifedipine extended-release tablets compared to placebo. The table lists effects such as headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation with corresponding percentages for both groups.*

FDA Label Image

Image4 (Image 04)

A text panel listing extended-release nifedipine tablets by strength (30 mg, 60 mg, 90 mg), color (yellow, pink, brown), and tablet markings. Markings include 'Novast' plus numerical codes specific to each strength.*

FDA Label Image

Image6 (Image 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.